Web13 ian. 2024 · REDWOOD CITY, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and Graphite Bio, Inc., a next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious … WebREDWOOD CITY, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndromes (MDS) as …
Jasper Therapeutics Appoints David Hinds as Senior Vice …
WebJasper Therapeutics Biotechnology Research Redwood City, CA 3,004 followers Jasper is a biotechnology company focused on enabling cures with stem cell transplants Web10 apr. 2024 · 10.04.2024 - REDWOOD CITY, Calif., April 10, 2024 (GLOBE NEWSWIRE) - Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel ... dr wayne yee portland maine
Scientist, Engineered Stem Cells Job in Redwood City, CA at Jasper ...
Web13 apr. 2024 · 4 brokers have issued 12 month target prices for Jasper Therapeutics' shares. Their JSPR share price forecasts range from $4.00 to $8.00. On average, they anticipate the company's share price to reach $6.21 in the next twelve months. This suggests a possible upside of 314.2% from the stock's current price. WebCITY, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briqui... 13 Apr 2024 13:07:28 WebRedwood City, California 94063 CALIFORNIA United States Email firm Visit website +1 650 463 4000 +1 650 463 4199. ... Engrail Therapeutics, Inc. RTW Investments. Tropos Technologies, Inc. Vexcel Imaging. ... She works alongside Jasper Howard, who deals with tax-free spin-offs and restructurings; ... dr waynick tn oncology